Literature DB >> 16877365

Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency.

Mika Suzuki1, Evangeline Sari Mose, Valerie Montel, David Tarin.   

Abstract

This study shows that solitary, dormant human cancer cells, retrieved from metastasis-free organs of animals carrying spontaneously metastatic primary tumors, can reactivate their tumorigenic and metastatic potency. The tumors were produced by MDA-MB-435 CL16 breast cancer cells permanently labeled with green fluorescent protein and the neomycin resistance gene. This enabled unequivocal identification of tumor cells emerging from organ explants cultured in neomycin to eliminate nonneoplastic host cells. Rescued cells resumed proliferation and generated lines that were tumorigenic and metastatic in fresh animals. All resulting primary and secondary tumors were uniformly labeled. Cells recovered from bone marrows and spleens, where there were no metastases, were as tumorigenic and metastatic as cells recovered from lungs and lymph nodes, which are the preferred sites of colonization for this tumor line. This evidence that malignant growth of disseminated cancer cells is suspended indefinitely by microenvironmental conditions in metastasis-free organs, although it is still active in others of the same host, shows that neoplastic progression can be arrested and has far-reaching biological and clinical implications. Specifically, it predicts the existence of natural, nonimmune host mechanisms that stimulate or inactivate tumor growth in different anatomical sites, which may be exploitable for therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877365      PMCID: PMC1698784          DOI: 10.2353/ajpath.2006.060053

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

Review 1.  The microenvironment of the tumour-host interface.

Authors:  L A Liotta; E C Kohn
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.

Authors:  Virginia Urquidi; Derek Sloan; Kanji Kawai; Dianne Agarwal; Anthony C Woodman; David Tarin; Steve Goodison
Journal:  Clin Cancer Res       Date:  2002-01       Impact factor: 12.531

3.  Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine.

Authors:  I J Fidler
Journal:  J Natl Cancer Inst       Date:  1970-10       Impact factor: 13.506

4.  Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate.

Authors:  S F Goldberg; J F Harms; K Quon; D R Welch
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

Review 5.  Tumour dormancy: findings and hypotheses from clinical research on breast cancer.

Authors:  R Demicheli
Journal:  Semin Cancer Biol       Date:  2001-08       Impact factor: 15.707

6.  Influence of microenvironment and vascular anatomy on "metastatic" colonization potential of mammary tumors.

Authors:  D Tarin; J E Price
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

7.  Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein.

Authors:  Steve Goodison; Kanji Kawai; Jun Hihara; Ping Jiang; Meng Yang; Virginia Urquidi; Robert M Hoffman; David Tarin
Journal:  Clin Cancer Res       Date:  2003-09-01       Impact factor: 12.531

8.  Tumor-stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis.

Authors:  Valérie Montel; Evangeline Sari Mose; David Tarin
Journal:  Int J Cancer       Date:  2006-07-15       Impact factor: 7.396

9.  GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice.

Authors:  Fayyaz Ahmed; Jeffrey Wyckoff; Elaine Y Lin; Weigang Wang; Yarong Wang; Lothar Hennighausen; Jun-ichi Miyazaki; Joan Jones; Jeffrey W Pollard; John S Condeelis; Jeffrey E Segall
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

Review 10.  The organ microenvironment and cancer metastasis.

Authors:  Isaiah J Fidler
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

View more
  43 in total

1.  Metastasis: The rude awakening.

Authors:  Jocelyn Rice
Journal:  Nature       Date:  2012-05-30       Impact factor: 49.962

Review 2.  Progress in refining the clinical management of cancer of unknown primary in the molecular era.

Authors:  Elie Rassy; Nicholas Pavlidis
Journal:  Nat Rev Clin Oncol       Date:  2020-04-29       Impact factor: 66.675

3.  Optical techniques for tracking multiple myeloma engraftment, growth, and response to therapy.

Authors:  Judith M Runnels; Alicia L Carlson; Costas Pitsillides; Brian Thompson; Juwell Wu; Joel A Spencer; John M J Kohler; AbdelKareem Azab; Anne-Sophie Moreau; Scott J Rodig; Andrew L Kung; Kenneth C Anderson; Irene M Ghobrial; Charles P Lin
Journal:  J Biomed Opt       Date:  2011 Jan-Feb       Impact factor: 3.170

Review 4.  Does tumour dormancy offer a therapeutic target?

Authors:  Paul E Goss; Ann F Chambers
Journal:  Nat Rev Cancer       Date:  2010-11-04       Impact factor: 60.716

Review 5.  Heterogeneity maintenance in glioblastoma: a social network.

Authors:  Rudy Bonavia; Maria-del-Mar Inda; Webster K Cavenee; Frank B Furnari
Journal:  Cancer Res       Date:  2011-05-31       Impact factor: 12.701

6.  Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells.

Authors:  Hideyuki Shimizu; Shoichiro Takeishi; Hirokazu Nakatsumi; Keiichi I Nakayama
Journal:  JCI Insight       Date:  2019-02-21

7.  The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis.

Authors:  Jason L Townson; Ian C Macdonald; Karen T Liby; Lisa Mackenzie; David W Dales; Benjamin D Hedley; Paula J Foster; Michael B Sporn; Ann F Chambers
Journal:  Clin Exp Metastasis       Date:  2011-01-15       Impact factor: 5.150

Review 8.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

9.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.

Authors:  Pushkar A Phadke; Kedar S Vaidya; Kevin T Nash; Douglas R Hurst; Danny R Welch
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

10.  Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry.

Authors:  Rikke Leth-Larsen; Rikke Lund; Helle V Hansen; Anne-Vibeke Laenkholm; David Tarin; Ole N Jensen; Henrik J Ditzel
Journal:  Mol Cell Proteomics       Date:  2009-03-24       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.